Idioma:

Comparison of Efficacy and Safety of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Versus Tricuspid Aortic Valves

Sannino, Anna ; Cedars, Ari ; Stoler, Robert C. ; Szerlip, Molly ; Mack, Michael J. ; Grayburn, Paul A.

The American journal of cardiology, 2017-11, Vol.120 (9), p.1601-1606 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Comparison of Efficacy and Safety of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Versus Tricuspid Aortic Valves
Autor: Sannino, Anna ; Cedars, Ari ; Stoler, Robert C. ; Szerlip, Molly ; Mack, Michael J. ; Grayburn, Paul A.
Assuntos: Aged ; Aged, 80 and over ; Aorta ; Aortic valve ; Aortic Valve - abnormalities ; Aortic Valve - pathology ; Aortic Valve - surgery ; Balloon treatment ; Bicuspid Aortic Valve Disease ; Calcification ; Cardiovascular diseases ; Clinical outcomes ; Cohort Studies ; Complications ; Consortia ; Effectiveness ; Electrocardiography ; Female ; Heart ; Heart Valve Diseases - mortality ; Heart Valve Diseases - pathology ; Heart Valve Diseases - surgery ; Heart valves ; Hemodynamics ; Humans ; Implantation ; Institutions ; Kidneys ; Male ; Medical imaging ; Middle Aged ; Morphology ; Mortality ; Patients ; Population ; Recovery of Function ; Rheumatic heart disease ; Safety ; Stenosis ; Stroke Volume ; Studies ; Success ; Survival Rate ; Transcatheter Aortic Valve Replacement ; Treatment Outcome
É parte de: The American journal of cardiology, 2017-11, Vol.120 (9), p.1601-1606
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Bicuspid aortic valve (BAV) stenosis has been considered a contraindication to transcatheter aortic valve implantation (TAVI). The aim of this study is to compare the efficacy and safety of TAVI in patients with BAV with those with tricuspid aortic valve (TAV) using balloon-expandable and self-expanding transcatheter heart valves. This retrospective study included 823 consecutive patients with severe, symptomatic aortic valve stenosis undergoing TAVI in 2 institutions, Baylor Heart and Vascular Hospital (Dallas, TX) and The Heart Hospital Baylor Plano (Plano, TX), from January 2012 to February 2016. Efficacy was evaluated by postprocedural valve function as mean gradient, peak velocity, effective orifice area, and ≥moderate paravalvular leak. Safety end points included all-cause 30-day and 1-year mortality, immediate postprocedural mortality and 30-day cardiovascular mortality, procedural success, pacemaker implantation, and procedural complications. Of the 823 included patients, 735 had TAV and 77 had BAV. Baseline characteristics were similar between the 2 groups. Procedural success was high in both BAV and TAV (98.7% vs 99.1%, p = ns). There were no significant differences between groups in valve hemodynamics after TAVI, pacemaker implantation rate, or procedural complications. There were no differences regarding immediate postprocedural mortality (BAV vs TAV, 1.1% vs 0.8%, p = ns), nor 30-day cardiovascular mortality (3.4% vs 2.3%, p = ns). All-cause mortality at 30 days (3.4% vs 3.1%, p = ns) and 1-year (8.5% vs 10.5%) were similar. Patients with BAV showed similar procedural and clinical outcomes to patients with TAV. Therefore, TAVI appears to be a safe and effective procedure for patients with BAVs as well as those with TAVs.
Editor: United States: Elsevier Inc
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Comparison of Efficacy and Safety of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Versus Tricuspid Aortic Valves

Sannino, Anna ; Cedars, Ari ; Stoler, Robert C. ; Szerlip, Molly ; Mack, Michael J. ; Grayburn, Paul A.

United States: Elsevier Inc

Buscando em bases de dados remotas. Favor aguardar.